Introduction
Mitobio is a mitochondrial biologic which extracted and purified from mitochondrial activated stem cells (Mitocell). Mitobio with excellent mitochondrial function verified by the mitochondrial function analysis platform (TAF certification). It is a new regenerative medicine biologic and can be regarded as a novel cell-free therapy, which has lower risks of genetic and rejection compared with stem cells. Mitobio can reverse the cellular damage by quickly entering the cell and replacing the damaged mitochondria. Mitobio can be applied to neurodegenerative diseases (Pa. Kinson's disease), myocardial damage, ischemic damage, aging and aging-related diseases, etc.
Features / strengths
Cell-free therapy
Organelles-based innovative biologics
The first standardized mitochondrial biologics
Allogeneic use
Specification in detail
Content
Exogenous mitochondria
Manufacture
Small-scale production is available; large-scale production is under development.
